1. Globalization, Intellectual Property Rights, and Pharmaceuticals: Meeting the Challenges to Addressing Health Gaps in the New International Environment; 2. Pharmaceutical Production and Access to Essential Medicines in South Africa; 3. Intellectual Property and Access to Medicines: Paradoxes in Moroccan Policy; 4. The Invisible Threat: Trade, Intellectual Property, and Pharmaceutical Regulations in Colombia; 5. The Challenges of Constructing Pharmaceutical Capabilities and Promoting Access to Medicines in Mexico under TRIPS; 6. Corporate Power and State Resistance: Brazil’s Use of TRIPS Flexibilities for its National AIDS Program Matthew Flynn; 7. The Politics of Patents and Drugs in Brazil and Mexico: The Industrial Bases of Health Policies; 8. Pharmaceutical Patent Policy in Developing Countries: Learning from the Canadian Experience; 9. Access to Indian Generic Drugs: Emerging Issues; 10. Sufficient but Expensive Drugs: A Double-Track System that Facilitated Supply Capability in China; 11. Access to Essential Drugs in Thailand: Intellectual Property Rights and Other Institutional Matters Affecting Public Health in a Developing Country; 12. The TRIPS Agreement and Health Innovation in Bangladesh.